EvoBiotech is an emerging company focused on the development of a technology platform for the delivery of nucleic acids and bioactive molecules and for the improvement of the efficacy of existing therapies for wound care.

Our team has extensive experience in the production and study of the regenerative properties of plant-derived extracellular vesicles. The team has also developed several engineering and loading strategies for using them as delivery systems for mRNA, nucleic acids, and other bioactive molecules.


Our mission is to provide innovative solutions for improving vaccine delivery strategies and the efficacy of wound care products. We are doing this by exploiting the natural properties of plant-derived extracellular vesicles.